In the reviewed studies, treatments without combination with an immunomodulating agent were usually followed by increased levels of CD8 in the treated tumor, with the exception of radiotherapy where the outcome was quite variable with even a few instances of a decrease in CD8. Here, CD8A is linked to neoplasm.